Knör, Sebastian <br/><br/>
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  Jan 2008 
 - 53-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1619-7089 
<br/><br/><label>Standard No.: </label>10.1007/s00259-007-0582-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alpha Particles--therapeutic use<br/>Animals<br/>Bismuth--chemistry<br/>Cell Line, Tumor<br/>Dimerization<br/>Drug Discovery<br/>Enzyme Inhibitors--chemistry<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Heterocyclic Compounds, 1-Ring--chemistry<br/>Humans<br/>Kidney--drug effects<br/>Ligands<br/>Mice<br/>Neoplasm Metastasis<br/>Ovarian Neoplasms--genetics<br/>Peptides--chemical synthesis<br/>Polygeline--pharmacology<br/>Radioisotopes<br/>Receptors, Urokinase Plasminogen Activator--antagonists & inhibitors<br/>Solubility<br/>Substrate Specificity<br/>Tissue Distribution